{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:25:00Z","timestamp":1774524300292,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Health Commission of the People\u2019s Republic of China","award":["2015ZX09101031"],"award-info":[{"award-number":["2015ZX09101031"]}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2016ZF003"],"award-info":[{"award-number":["2016ZF003"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2016-I2M-1-019"],"award-info":[{"award-number":["2016-I2M-1-019"]}]},{"name":"Special Funds for high-level health talents of Yunnan Province","award":["D-201669"],"award-info":[{"award-number":["D-201669"]}]},{"name":"Special Funds for high-level health talents of Yunnan Province","award":["L-201615"],"award-info":[{"award-number":["L-201615"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.11.020","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:53:39Z","timestamp":1542675219000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing"],"prefix":"10.1016","volume":"37","author":[{"given":"Yan","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lujie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-7863","authenticated-orcid":false,"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.020_b0005","unstructured":"Organization WH. Polio eradication & endgame strategic plan 2013\u20132018. Global Polio Eradication Initiative, working draft 2013;23:1\u201399."},{"key":"10.1016\/j.vaccine.2018.11.020_b0010","series-title":"WHO global action plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use","author":"Organization","year":"2015"},{"key":"10.1016\/j.vaccine.2018.11.020_b0015","unstructured":"WHO Representative Office in China. New poliovirus vaccine licensed in China. [updated 2015-01-15; cited 2018-01-08] http:\/\/www.wpro.who.int\/china\/mediacentre\/releases\/2015\/20150115\/en\/."},{"key":"10.1016\/j.vaccine.2018.11.020_b0020","series-title":"The use of in vitro markers and monkey neurovirulence tests to follow genetic changes in attenuated poliovirus multiplying in the human alimentary tract","first-page":"179","author":"Benyesh-Melnick","year":"1959"},{"key":"10.1016\/j.vaccine.2018.11.020_b0025","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1093\/nar\/12.20.7787","article-title":"Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine","volume":"12","author":"Cann","year":"1984","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.vaccine.2018.11.020_b0030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/314548a0","article-title":"Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome","volume":"314","author":"Evans","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.11.020_b0035","unstructured":"Organization WH. Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated). WHO Expert Committee on Biological Standardization Sixty-third report 2014;TRS 980:49\u2013140."},{"key":"10.1016\/j.vaccine.2018.11.020_b0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/biol.1996.0010","article-title":"A poliovirus-susceptible transgenic mouse model as a possible replacement for the Monkey Neurovirulence Test of oral poliovirus vaccine","volume":"24","author":"Dragunsky","year":"1996","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.11.020_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0264-410X(00)00190-0","article-title":"Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993\u20131999","volume":"19","author":"Levenbook","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.020_b0050","doi-asserted-by":"crossref","first-page":"20063","DOI":"10.1073\/pnas.1012537107","article-title":"Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines","volume":"107","author":"Neverov","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2018.11.020_b0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nmeth1156","article-title":"Next-generation sequencing transforms today's biology","volume":"5","author":"Schuster","year":"2007","journal-title":"Nat Methods"},{"key":"10.1016\/j.vaccine.2018.11.020_b0060","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1086\/597808","article-title":"Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)\u2013treated patients and NRTI-naive patients","volume":"199","author":"Margeridon-Thermet","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.020_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-4690-6-15","article-title":"Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations","volume":"6","author":"Rozera","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.vaccine.2018.11.020_b0070","doi-asserted-by":"crossref","first-page":"e1000896","DOI":"10.1371\/journal.ppat.1000896","article-title":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing","volume":"6","author":"Eckerle","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.11.020_b0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/JCM.05715-11","article-title":"Use of illumina deep sequencing technology to differentiate hepatitis C virus variants","volume":"50","author":"Ninomiya","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.020_b0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.020_b0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.vaccine.2018.11.020_b0090","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2018.11.020_b0095","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","article-title":"VarScan: variant detection in massively parallel sequencing of individual and pooled samples","volume":"25","author":"Koboldt","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2018.11.020_b0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat Methods."},{"key":"10.1016\/j.vaccine.2018.11.020_b0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: a revolutionary tool for transcriptomics","volume":"10","author":"Wang","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.vaccine.2018.11.020_b0110","doi-asserted-by":"crossref","first-page":"e1006155","DOI":"10.1371\/journal.ppat.1006155","article-title":"RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation","volume":"13","author":"Wilson","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.11.020_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-1119(85)90017-4","article-title":"The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance\u2013a review","volume":"40","author":"Domingo","year":"1985","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2018.11.020_b0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19","volume":"175","author":"Conzelmann","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.11.020_b0125","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.83.11.3914","article-title":"Walking along the rabies genome: is the large G-L intergenic region a remnant gene?","volume":"83","author":"Tordo","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.11.020_b0130","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/JVI.02301-08","article-title":"Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis","volume":"83","author":"Victoria","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.11.020_b0135","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pbio.0050082","article-title":"Environmental shotgun sequencing: its potential and challenges for studying the hidden world of microbes","volume":"5","author":"Eisen","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2018.11.020_b0140","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/1471-2164-14-444","article-title":"Next generation sequencing of viral RNA genomes","volume":"14","author":"Marston","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2018.11.020_b0145","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.02690-09","article-title":"Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus","volume":"84","author":"Victoria","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.11.020_b0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jviromet.2017.04.016","article-title":"Quantifying low-frequency revertants in oral poliovirus vaccine using next generation sequencing","volume":"246","author":"Sarcey","year":"2017","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2018.11.020_b0155","unstructured":"Organization WH. Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (inactivated). WHO Expert Committee on Biological Standardization Sixty-fifth report. 2015;TRS 993:89\u2013172."},{"key":"10.1016\/j.vaccine.2018.11.020_b0160","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JVI.66.2.966-970.1992","article-title":"RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence","volume":"66","author":"Chumakov","year":"1992","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T15:14:23Z","timestamp":1605453263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18315433"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}